Print

A well-balanced and diversified product portfolio

In both its targeted therapeutic areas and primary care, Ipsen has a diversified portfolio of leading drugs.

The Group's product portfolio includes pharmaceutical products marketed around the world to specialists working in its targeted therapeutic areas (neurology, endocrinology, uro-oncology, hematology), which are its primary areas of development. The Group also markets products in other therapeutic areas in which it boasts longstanding expertise (gastroenterology, cardiovascular and cognitive disorders). To a large extent, these are composed of primary care.